High Mobility provides an infrastructure for connected car data, enabling users to connect multi-brand fleets from a single interface. The service handles data privacy, pricing, and technical challenges, while delivering car data from official sources.

High Mobility

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Intellia Therapeutics, Inc

ITS International specializes in providing news and insights related to intelligent transportation systems and services. It covers various aspects of the transportation industry from air quality monitoring to urban traffic control. Self-described as a leading publication in its field.

ITS International

VISPIRON offers solutions for sustainable energy and mobility, focusing on climate-neutral products and services. It provides digitalization and management of vehicle fleets, development of solar parks, and charging infrastructure.

Metric
Company Name	High Mobility	Intellia Therapeutics, Inc	ITS International	VISPIRON
Symbol		NTLA
MSH ID	COM:HIGH-MOBILITY	COM:INTELLIATX	COM:ITSINTERNATIONAL	COM:VISPIRON
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Technology	Healthcare	Commercial & Professional Services	Energy
Industry	Automotive Technology	Biotechnology	Transportation	Renewable Energy
Country	DE	US	US	DE
Stage
Employee Count		598		251
Website	high-mobility.com	intelliatx.com	itsinternational.com	vispiron.com
LinkedIn			international-traffic-systems
Founders

Metric
Market Cap		1.55B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		36.27M
Revenue (LTM)
Revenue (NTM)
Gross Profit		27.30M
EBITDA		-506.21M
Operating Income		-515.29M
Net Income		-481.19M
EPS		-5.42
Diluted EPS		-5.42
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.84
Operating Profit Margin		-9.83
EBITDA Margin		-13.95
Net Profit Margin		-9.23
Return on Equity		-0.43
Return on Assets		-0.36
Return on Capital Employed		-0.43

COM:HIGH-MOBILITY

High Mobility

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-4.82
P/B Ratio		2.11
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		71.40
EV Multiple		-3.49

Metric
Days Sales Outstanding		45.77
Days Payables Outstanding
Days Inventory Outstanding		0.00
Operating Cycle		366.82
Cash Conversion Cycle		63.79
Asset Turnover		0.04

Metric
Operating Cash Flow		-394.09M
Free Cash Flow		-408.07M
Cash Flow to Debt		-2.96
Operating Cash Flow/Sales		-6.85
Free Cash Flow Yield		-0.18

Metric
Cash & Equivalents		226.75M
Accounts Receivable		-32.69M
Inventory
Goodwill
Debt to Capitalization		0.10
Debt to Assets		0.10
Current Ratio		9.72
Quick Ratio		9.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		2.39
R&D to Revenue		8.23
SG&A to Revenue		2.15